Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

BACKGROUND: Although implantation of cardiac implantable electronic devices (CIEDs) in patients receiving warfarin is well studied, limited data are available on the use of oral factor Xa inhibitors in this setting. METHODS AND RESULTS: Using data from Rivaroxaban Once Daily Oral Direct Factor Xa In...

詳細記述

保存先:
書誌詳細
出版年:J Am Heart Assoc
主要な著者: Leef, George C., Hellkamp, Anne S., Patel, Manesh R., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Halperin, Jonathan L., Hankey, Graeme J., Hacke, Werner, Nessel, Christopher C., Singer, Daniel E., Fox, Keith A.A., Mahaffey, Kenneth W., Piccini, Jonathan P.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2017
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669143/
https://ncbi.nlm.nih.gov/pubmed/28615214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.004663
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料